Reducing human suffering by detecting cancer earlier with patented technology
BioCurex's RECAF(tm) marker is found in all types of major cancers
  • Demo Video
  • Private Messages
  • Edit My Profile
  • View/Edit Portfolio

Email Updates

Search

AGORACOM News Flash

AGORACOM WIRE - MONDAY MAY 28TH, 2012

SONOMAX completes $3 million equity financing

FOCUS METALS (TSXV:FMS) Changes Its Name to Focus Graphite Inc. Read More   |   *SPONSOR

INTERNATIONAL PBX VENTURES (TSX:PBX) Signs Copaquire Joint Venture Option Agreement - $90M Potential Payment Read More

LOMIKO METALS (TSXV:LMR) Graphite and Zinc Price Outlook is Favourable Through 2013  Read More   |   *SPONSOR

 

 

Message: The real story on the loan(s)

Al_bundy_400_profile
Rank: [?]
Vice President
Points: [?]
1181
Rating: [?]
Votes: 15 Score: 3.6
  • Currently 3.6/5 Stars.
Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.

The real story on the loan(s)

posted on Oct 22, 09 07:02PM

On June 29, 2007, Biocurex sold convertible notes, plus warrants, to two private investors for $3,000,000.

Keep in mind the following 1. All defaults under the Notes are waived provided that:

o Biocurex receives at least $350,000 from the sale of promissory notes prior to October 1, 2009; and

o Biocurex receives gross proceeds of at least $3,000,000 from the public sale of its securities (the "Public Offering");

o Biocurex uses the greater of $600,000 or 20% of the proceeds from the public sale of its securities to repay the notes.

Advancements require Money. This is a Fact of Life in the business world. Dr. Moro did not "Toss the Money away" He used it in the following areas. He will use our new money to drive Recaf all the way to the finish line. Mark My Words!

Since June of 2007 the following advancements have been made:

http://www.biocurex.com/curexhtml/news/news94.htm

http://www.biocurex.com/curexhtml/news/news95.htm

http://www.biocurex.com/curexhtml/news/news97.htm

http://www.biocurex.com/curexhtml/news/news100.htm

http://www.biocurex.com/curexhtml/news/news101.htm

http://www.biocurex.com/curexhtml/news/news102.htm

http://www.biocurex.com/curexhtml/news/news104.htm

http://www.biocurex.com/curexhtml/news/news105.htm

http://www.biocurex.com/curexhtml/news/news106.htm

http://www.biocurex.com/curexhtml/news/news108.htm

http://www.biocurex.com/curexhtml/news/news109.htm

http://www.biocurex.com/curexhtml/news/news111.htm

http://www.biocurex.com/curexhtml/news/news112.htm

http://www.biocurex.com/curexhtml/news/news113.htm

http://www.biocurex.com/curexhtml/news/news114.htm

http://www.reuters.com/article/pressRelease/idUS153540+24-Jul-2008+MW20080724

New Message

Please login to post a reply

AGORACOM Quick Tips

Breaking Small-Cap News Delivered to your Smart Phone! Grab our RSS Feed

President's D.D.

New feature: Hub Presidents can add important links here.

Stock Quote